Evidence map›Paper›PMID 35692702›Full record

ReviewPrecision clinical medicine2018

Timing and mode of intervention for patients with left sided valvular heart disease: an individualized approach.

Hannah McConkey, Zhengang Zhao, S Redwood, M Chen, B D Prendergast

Open access · diamondAbstract readReview
In one paragraph

Review in Precision clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Hannah McConkeyKing's College London British Heart Foundation Centre of Excellence, The Rayne Institute, St. Thomas' Hospital Campus, London, United Kingdom, and the Department of Cardiology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Zhengang ZhaoDepartment of Cardiology, West China Hospital, Sichuan University.
S RedwoodKing's College London British Heart Foundation Centre of Excellence, The Rayne Institute, St. Thomas' Hospital Campus, London, United Kingdom, and the Department of Cardiology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
M ChenDepartment of Cardiology, West China Hospital, Sichuan University.
B D PrendergastKing's College London British Heart Foundation Centre of Excellence, The Rayne Institute, St. Thomas' Hospital Campus, London, United Kingdom, and the Department of Cardiology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
British Heart Foundation · GBGuy's and St Thomas' NHS Foundation Trust · GBSichuan University · CNSt Thomas' Hospital · GBWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left sided valvular heart disease poses major impact on life and lifestyle. Medical therapy merely palliates chronic severe valve disease and once symptoms or haemodynamic sequelae appear, life expectancy is markedly truncated. In this article, we review the mechanisms of valve pathology, latest evidence in the quest for pharmacological options, means by which to predict deterioration, and standard and novel treatment options.

Identifiers

PMID35692702
PMCPMC8985789
OpenAlexW2904970284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.